| Literature DB >> 28773116 |
Flavia Bollino1, Emilia Armenia2, Elisabetta Tranquillo3.
Abstract
Zirconia (Entities:
Keywords: Fourier transform infrared spectroscopy (FTIR) analysis; bioactivity; biocompatibility; sol-gel method
Year: 2017 PMID: 28773116 PMCID: PMC5551800 DOI: 10.3390/ma10070757
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Fourier transform infrared spectroscopy (FTIR) of (a) ZrO2; (b) hydroxyapatite (Hap); (c) 9ZrO2∙1Hap; (d) 7ZrO2∙3Hap; and (e) 5ZrO2∙5HAp gels, heated to 120 °C and (f) Ca(NO3)2 4H2O.
Figure 2FTIR of (a) ZrO2; (b) Hap; (c) 9ZrO2∙1Hap; (d) 7ZrO2∙3Hap; and (e) 5ZrO2∙5HAp gels, heated to 600 °C.
Figure 3FTIR of (a) ZrO2; (b) Hap; (c) 9ZrO2∙1Hap; (d) 7ZrO2∙3Hap; and (e) 5ZrO2∙5HAp gels, heated to 1000 °C.
Figure 4FTIR of (a) bovine serum albumin (BSA) and (b) ZrO2; (c) Hap; (d) 9ZrO2∙1Hap; (e) 7ZrO2∙3Hap; and (f) 5ZrO2∙5HAp gels, heated to 600 °C, after 24 h of exposure to the BSA solution.
Figure 5FTIR of (a) BSA and (b) ZrO2; (c) Hap; (d) 9ZrO2∙1Hap; (e) 7ZrO2∙3Hap; and (f) 5ZrO2∙5HAp gels, heated to 1000 °C, after 24 h of exposure to BSA solution.
Figure 6Cytotoxicity assay results. CTR: Control.
Figure 7FTIR of (a) ZrO2; (b) Hap; (c) 9ZrO2∙1Hap; (d) 7ZrO2∙3Hap; and (e) 5ZrO2∙5HAp gels, heated to 600 °C, after 21 days of exposure to Simulated Body Fluid (SBF).
Figure 8FTIR of (a) ZrO2; (b) HAp; (c) 9ZrO2∙1Hap; (d) 7ZrO2∙3Hap; and (e) 5ZrO2∙5HAp gels, heated to 1000 °C, after 21 days of exposure to SBF.
Figure 9SEM images of all samples heated to 600 °C and 1000 °C after 21 days of exposure to SBF.
Figure 10Representative Energy Dispersive X-ray analysis (EDX) images of the globular precipitate on the surface of the samples heated to (a) 600 °C and (b) 1000 °C after 21 days of exposure to SBF.
Figure 11Flow chart of the sol-gel synthesis and heat treatments.